Melofresh 30 Tablet contains a combination of Flupenthixol (0.5 mg) and Melitracen (10 mg), which is primarily indicated for the treatment of depressive disorders and associated anxiety. Flupenthixol, a typical antipsychotic agent, exerts its therapeutic effect by antagonizing dopamine receptors, thereby modulating neurotransmitter activity in the central nervous system. Melitracen, a tricyclic antidepressant, enhances the levels of norepinephrine and serotonin by inhibiting their reuptake, contributing to mood elevation and anxiolytic properties. The synergistic action of these two components provides effective relief from symptoms of depression, anxiety, and psychosomatic disorders. Melofresh 30 is prescribed for patients experiencing mild to moderate depression, particularly when accompanied by anxiety or agitation. The recommended dosage should be determined by a healthcare professional based on individual patient needs and response to treatment. Caution is advised in patients with a history of cardiovascular disease, glaucoma, or epilepsy. Common side effects may include dry mouth, dizziness, sedation, and gastrointestinal disturbances. It is contraindicated in individuals with hypersensitivity to either component, and abrupt discontinuation should be avoided to prevent withdrawal symptoms. Regular monitoring is essential to ensure efficacy and safety during the course of therapy.